Photobleaching kinetics of Photofrin in vivo and in multicell tumour spheroids indicate two simultaneous bleaching mechanisms.

We present a detailed investigation of Photofrin photobleaching and photoproduct accumulation. Fisher rats were sensitized with 10 mg kg(-1) Photofrin and irradiated 24 h later with 514 nm light at 5 or 100 mW cm(-2). Fluorescence spectra were collected from the skin throughout treatment, and sensitizer bleaching and fluorescent photoproduct formation were quantified using spectral analysis. Photofrin bleaching was slightly more rapid at the higher irradiance under these conditions. However, accumulation of photoproduct was significantly enhanced at lower irradiance. To interpret these unexpected findings, we developed a new mathematical model in which reactions between singlet oxygen (1O2) and the photosensitizer and reactions between the sensitizer triplet and biological targets are both allowed to contribute to bleaching. Predictions of this model were tested in experiments performed on EMT6 spheroids sensitized with concentrations of 2.5, 10 and 30 microg mL(-1) Photofrin and subjected to PDT. Photofrin bleaching and photoproduct formation in these spheroids were measured using confocal fluorescence spectroscopy. In qualitative agreement with the mixed-mechanism model predictions, at the highest drug concentration Photofrin bleaching was more efficient via 1O2 reactions, while at the lowest concentration triplet reactions were more efficient. At all concentrations, photoproduct accumulation was greater under conditions of abundant oxygen.

[1]  B. Henderson,et al.  Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. , 1998, British Journal of Cancer.

[2]  T. Foster,et al.  Confocal fluorescence spectroscopy and anisotropy imaging system. , 2003, Optics letters.

[3]  T. Foster,et al.  Singlet Oxygen‐Versus Nonsinglet Oxygen‐Mediated Mechanisms of Sensitizer Photobleaching and Their Effects on Photodynamic Dosimetry , 1998, Photochemistry and photobiology.

[4]  Thomas S. Mang,et al.  THE THEORY OF PHOTODYNAMIC THERAPY DOSIMETRY: CONSEQUENCES OF PHOTO‐DESTRUCTION OF SENSITIZER , 1987 .

[5]  Jarod C. Finlay,et al.  Reflectance and fluorescence spectroscopies in photodynamic therapy , 2004 .

[6]  W. M. Star Comparing the P3-approximation with diffusion theory and with Monte Carlo calculations of light propagation in a slab geometry , 1989, Other Conferences.

[7]  E. Hull,et al.  Porphyrin Bleaching and PDT-induced Spectral Changes are Irradiance Dependent in ALA-sensitized Normal Rat Skin In Vivo¶ , 2001, Photochemistry and photobiology.

[8]  R. Rava,et al.  Analytical model for extracting intrinsic fluorescence in turbid media. , 1993, Applied optics.

[9]  J. Kennedy,et al.  A recipe for the preparation of a rodent food that eliminates chlorophyll-based tissue fluorescence. , 1995, Journal of photochemistry and photobiology. B, Biology.

[10]  J Moan,et al.  Photoproducts formed from photofrin II in cells. , 1988, Journal of photochemistry and photobiology. B, Biology.

[11]  W. Potter,et al.  PHOTOBLEACHING OF PHOTOFRIN II AS A MEANS OF ELIMINATING SKIN PHOTOSENSITIVITY * , 1987, Photochemistry and photobiology.

[12]  M G Nichols,et al.  The Mechanism of Photofrin Photobleaching and Its Consequences for Photodynamic Dosimetry , 1997, Photochemistry and photobiology.

[13]  J. Spikes QUANTUM YIELDS AND KINETICS OF THE PHOTOBLEACHING OF HEMATOPORPHYRIN, PHOTOFRIN II, TETRA(4‐SULFONATOPHENYL)‐PORPHINE AND UROPORPHYRIN , 1984 .

[14]  K König,et al.  Variation in the fluorescence decay properties of haematoporphyrin derivative during its conversion to photoproducts. , 1990, Journal of photochemistry and photobiology. B, Biology.

[15]  M G Nichols,et al.  Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. , 1994, Physics in medicine and biology.

[16]  S. Gibson,et al.  Effects of various photoradiation regimens on the antitumor efficacy of photodynamic therapy for R3230AC mammary carcinomas. , 1990, Cancer research.

[17]  J Moan,et al.  PHOTOBLEACHING OF PORPHYRINS USED IN PHOTODYNAMIC THERAPY AND IMPLICATIONS FOR THERAPY , 1987, Photochemistry and photobiology.

[18]  R. Feins,et al.  Photodynamic therapy for human malignant mesothelioma in the nude mouse. , 1990, The Journal of surgical research.

[19]  Edward B. Saff,et al.  Fundamentals of Differential Equations , 1989 .

[20]  Q. Peng,et al.  Uptake and distribution of intravenously or intravesically administered photosensitizers in the rat. , 1993, Cancer letters.

[21]  T. Foster,et al.  Oxygen consumption and diffusion effects in photodynamic therapy. , 1991, Radiation research.

[22]  B. Henderson,et al.  The Effect of Fluence Rate on Tumor and Normal Tissue Responses to Photodynamic Therapy , 1998, Photochemistry and photobiology.

[23]  Retrofitted confocal laser scanner for a commercial inverted fluorescence microscope , 2001 .

[24]  T. Foster,et al.  Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. , 1994, British Journal of Cancer.

[25]  Steven L. Jacques,et al.  Simple optical theory for light dosimetry during PDT (Invited Paper) , 1992, Photonics West - Lasers and Applications in Science and Engineering.

[26]  S. Mitra,et al.  Photodynamic therapy: Biophysical mechanisms and molecular responses , 2004 .

[27]  Michele T. Cooper,et al.  Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. , 2000, Cancer research.

[28]  J Moan,et al.  Effect of bleaching of porphyrin sensitizers during photodynamic therapy. , 1986, Cancer letters.